This approach could enable initial treatment with highly effective but expensive GLP-1 agonists, followed by maintenance with more affordable alternatives
Novo Nordisk has been competing with US competitor, Eli Lilly
Discuss whether your genetic profile, biomarker status, cost constraints, and clinical goals align better with semaglutide, tirzepatide, or dual-compound approachesall decisions that should involve your healthcare provider
In some cases, individuals may choose to use both glutathione and NAC, with guidance from a healthcare provider, to optimize their antioxidant support and address specific health concerns
Additionally, compounded semaglutide is suitable for those patients who cannot access branded semaglutide